Skip to main navigation Skip to search Skip to main content

Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.

  • University of Würzburg
  • University Hospitals Plymouth NHS Trust

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience